Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 14.78 M | $2.02 B | 3.69% | 14.72% |
| VANGUARD GROUP INC | 02/11/2025 | 10.12 M | $1.38 B | 1.23% | 10.01% |
| STATE STREET CORP | 02/14/2025 | 4.89 M | $667.65 M | -5.00% | 4.84% |
| DODGE & COX | 02/13/2025 | 3.02 M | $411.74 M | 134.23% | 3.00% |
| CITADEL ADVISORS LLC | 02/14/2025 | 2.54 M | $346.45 M | 43.84% | 2.53% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 2.49 M | $339.80 M | -3.31% | 2.48% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.90 M | $258.93 M | 2.91% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.88 M | $255.52 M | 0.85% | 1.87% |
| BELLEVUE GROUP AG | 02/14/2025 | 1.82 M | $248.43 M | -2.35% | 1.81% |
| MORGAN STANLEY | 02/14/2025 | 1.57 M | $214.76 M | 16.59% | 1.57% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.49 M | $203.46 M | -11.02% | 1.47% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 1.46 M | $198.94 M | 102.92% | 1.45% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.37 M | $187.17 M | -8.46% | 1.36% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 1.07 M | $146.07 M | 19.67% | 1.07% |
| NORTHERN TRUST CORP | 02/14/2025 | 981,939 | $134.03 M | 27.26% | 0.98% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 983,799 | $134.29 M | -3.28% | 0.97% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 944,738 | $128.96 M | 15.22% | 0.94% |
| INVESCO LTD. | 02/13/2025 | 949,512 | $129.61 M | 8.56% | 0.94% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 938,120 | $128.05 M | 210.41% | 0.93% |
| DSM CAPITAL PARTNERS LLC | 01/31/2025 | 932,595 | $127.30 M | -1.22% | 0.93% |
| BRAIDWELL LP | 02/14/2025 | 901,790 | $123.09 M | -1.73% | 0.90% |
| BROWN ADVISORY INC | 02/14/2025 | 898,293 | $122.62 M | -4.65% | 0.89% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 892,000 | $121.76 M | 391.78% | 0.89% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 870,290 | $118.79 M | 1.40% | 0.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 862,000 | $117.66 M | -34.53% | 0.86% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 843,902 | $115.19 M | 100.00% | 0.84% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 820,694 | $112.02 M | 145.13% | 0.82% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 794,118 | $108.40 M | 0.24% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 762,557 | $104.09 M | 2.04% | 0.75% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 02/14/2025 | 748,359 | $102.15 M | 1.55% | 0.75% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/10/2025 | 737,772 | $100.71 M | 2,759.36% | 0.73% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 720,500 | $98.35 M | -23.27% | 0.72% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 611,119 | $83.42 M | -27.44% | 0.61% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 608,935 | $83.12 M | -8.34% | 0.61% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 577,616 | $78.84 M | -9.31% | 0.58% |
| IEQ CAPITAL, LLC | 02/03/2025 | 557,904 | $76.15 M | 8.86% | 0.56% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 550,157 | $75.10 M | 5.07% | 0.54% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 514,082 | $70.17 M | 0.78% | 0.51% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 512,820 | $70.00 M | 21.88% | 0.51% |
| FIERA CAPITAL CORP | 01/29/2025 | 499,109 | $68.13 M | -3.42% | 0.50% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 484,034 | $66.07 M | -22.38% | 0.48% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 480,565 | $66.25 M | -30.35% | 0.48% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 461,782 | $63.03 M | 5.47% | 0.46% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 02/12/2025 | 453,091 | $61.85 M | -1.96% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 418,712 | $57.15 M | 33.87% | 0.42% |
| UBS GROUP AG | 02/14/2025 | 419,428 | $57.25 M | 16.65% | 0.41% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 413,479 | $56.44 M | -16.65% | 0.41% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 393,710 | $53.74 M | -2.55% | 0.39% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 394,652 | $53.87 M | -27.50% | 0.39% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 355,058 | $48.47 M | 34.90% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 787 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
Sendero Wealth Management, LLC: 0
Clarus Wealth Advisors: 0
BlackRock, Inc.: 14.78 M
VANGUARD GROUP INC: 10.12 M
STATE STREET CORP: 4.89 M
DODGE & COX: 3.02 M
93.98% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 133.59 M shares in the last 24 months. This purchase volume represents approximately $12.14 B in transactions.